Laurus Labs Ltd. (LAURUSLABS) Price & Analysis

Compare

11 Followers

LAURUSLABS Stock Chart & Stats

₹1107.05

-₹1.35(-0.22%)

At close: Jan 08 4:00 PM EST

₹1107.05

-₹1.35(-0.22%)

Day’s Range― - ―

52-Week Range₹517.05 - ₹1,140.90

Previous CloseN/A

Volume1.25M

Average Volume (3M)107.31K

Market Cap

₹553.62B

Enterprise Value₹575.48B

Total Cash (Recent Filing)₹1.44B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)59.4

Beta1.18

Next Earnings

Apr 23, 2026

EPS Estimate

4.89

Next Dividend Ex-DateN/A

Dividend Yield0.15%

Share Statistics

EPS (TTM)4.70

Shares Outstanding539,856,570

10 Day Avg. Volume186,027

30 Day Avg. Volume107,314

Financial Highlights & Ratios

PEG Ratio0.73

Price to Book (P/B)7.23

Price to Sales (P/S)5.82

P/FCF Ratio-821.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,225.00

Price Target Upside10.65% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)15.86

Revenue Forecast (FY)₹68.38B

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained ~27% revenue growth indicates expanding end-market traction and increasing scale. Over a 2–6 month horizon this supports stronger operating leverage, deeper customer relationships in ARV and other segments, and better resource allocation for capacity and compliance.

Gross Profit Margin StrengthA persistently strong gross margin implies cost-efficient manufacturing and favorable product mix. This durability helps absorb SG&A and R&D investments, supports reinvestment into capacity or regulatory compliance, and cushions competitive pricing pressure over the medium term.

Diversified Pharma Business ModelExposure to APIs, finished dosage formulations and CDMO services plus institutional ARV demand provides multiple revenue streams. This structural diversification reduces single-product risk, smooths revenue volatility from tenders, and supports repeatable contract-based cash flows.

Bears Say

Negative Free Cash FlowPersistent negative free cash flow from elevated capex erodes liquidity and forces external financing or slower deleveraging. Over months this constrains operational flexibility, increases reliance on debt or equity, and limits the ability to fund dividends or opportunistic investments internally.

Net Margin CompressionDeclining net margins despite strong gross margins point to rising operating or financial costs. If this trend persists it will weaken return metrics and internal funding capacity, pressuring ROE and making it harder to sustain R&D, regulatory spend, or competitive pricing without external capital.

Rising Liabilities / Declining Equity RatioA falling equity ratio and moderate leverage reduce financial headroom and elevate refinancing risk. Coupled with negative FCF, higher liabilities constrain strategic flexibility, increase interest burden sensitivity, and raise downside risk if market conditions or margins deteriorate.

Laurus Labs Ltd. News

Laurus Labs Releases Q2 FY26 Results Conference Call Recording

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has provided an announcement. Laurus Labs Ltd. announced the availability of the...

5M ago

Laurus Labs Secures Land for Major Expansion in Andhra Pradesh

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has issued an update. Laurus Labs Ltd. has been allotted 531.77 acres...

7M ago

Laurus Labs Conducts 20th AGM with Key Stakeholders

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) has issued an announcement. Laurus Labs Ltd. held its 20th Annual General...

9M ago

Laurus Labs Conducts 20th AGM with E-Voting Transparency

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) just unveiled an update. Laurus Labs Ltd. held its 20th Annual General...

9M ago

Laurus Labs to Discuss FY25 Earnings in Upcoming Conference Call

An update from Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) is now available. Laurus Labs Ltd has announced a...

11M ago

Laurus Labs Ensures Compliance with SEBI Regulations for Q1 2025

Laurus Labs Ltd. ( ($IN:LAURUSLABS) ) just unveiled an update. Laurus Labs Ltd. has announced the submission of...

11M ago

LAURUSLABS FAQ

What was Laurus Labs Ltd.’s price range in the past 12 months?

Laurus Labs Ltd. lowest stock price was ₹517.05 and its highest was ₹1140.90 in the past 12 months.

What is Laurus Labs Ltd.’s market cap?

Laurus Labs Ltd.’s market cap is ₹553.62B.

When is Laurus Labs Ltd.’s upcoming earnings report date?

Laurus Labs Ltd.’s upcoming earnings report date is Apr 23, 2026 which is in 45 days.

How were Laurus Labs Ltd.’s earnings last quarter?

Laurus Labs Ltd. released its earnings results on Jan 23, 2026. The company reported ₹4.7 earnings per share for the quarter, beating the consensus estimate of ₹3.675 by ₹1.025.

Is Laurus Labs Ltd. overvalued?

According to Wall Street analysts Laurus Labs Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Laurus Labs Ltd. pay dividends?

Laurus Labs Ltd. pays a Notavailable dividend of ₹0.8 which represents an annual dividend yield of 0.15%. See more information on Laurus Labs Ltd. dividends here

What is Laurus Labs Ltd.’s EPS estimate?

Laurus Labs Ltd.’s EPS estimate is 4.89.

How many shares outstanding does Laurus Labs Ltd. have?

Laurus Labs Ltd. has 539,856,570 shares outstanding.

What happened to Laurus Labs Ltd.’s price movement after its last earnings report?

Laurus Labs Ltd. reported an EPS of ₹4.7 in its last earnings report, beating expectations of ₹3.675. Following the earnings report the stock price went up 1.214%.

Which hedge fund is a major shareholder of Laurus Labs Ltd.?

Currently, no hedge funds are holding shares in IN:LAURUSLABS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Laurus Labs Ltd.

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.

Laurus Labs Ltd. (LAURUSLABS) Earnings & Revenues

Historic Earnings Reports

LAURUSLABS Stock 12 Month Forecast

Average Price Target

₹1,225.00

▲(10.65% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"525":"₹525","714":"₹714","903":"₹903","1092":"₹1,092","1281":"₹1,281"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1280,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.28K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.23K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.17K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[525,714,903,1092,1281],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1064.95,1081.4923076923078,1098.0346153846153,1114.576923076923,1131.1192307692309,1147.6615384615384,1164.2038461538461,1180.746153846154,1197.2884615384614,1213.8307692307692,1230.373076923077,1246.9153846153845,1263.4576923076922,{"y":1280,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1064.95,1077.2615384615385,1089.573076923077,1101.8846153846155,1114.196153846154,1126.5076923076924,1138.8192307692307,1151.1307692307691,1163.4423076923076,1175.753846153846,1188.0653846153846,1200.376923076923,1212.6884615384615,{"y":1225,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1064.95,1073.0307692307692,1081.1115384615384,1089.1923076923076,1097.273076923077,1105.3538461538462,1113.4346153846154,1121.5153846153846,1129.5961538461538,1137.676923076923,1145.7576923076924,1153.8384615384616,1161.9192307692308,{"y":1170,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":526.69,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":597.04,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":602.48,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":610.84,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":745.38,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":847.35,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":859.49,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":871.33,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":954.5,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1028.95,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1110.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":953.9,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1064.95,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >